Additional file 1: Supplementary File 1. Database information by drug/biomarker and recommendations, outcomes, and additional information from SmPC
Characteristics of the pathways obtained by functional enrichment analysis when considering the remi...
Description and statistics referred to the SNPs that showed p<0.05 (response phenotype) in both the ...
Additional file 1. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Proto...
Additional file 2: Supplementary File 2. Identification of the studies/publications included in the ...
Additional file 3: Supplementary File 3. Characterization of the studies/publications according to t...
Additional file 5: Supplementary File 5. Levels of evidence and GRADE of the studies included in the...
Additional file 4: Supplementary File 4. Tables with the results related to the drugs, namely the in...
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...
MOOSE Checklist. A list of factors that have been checked or done for this meta-analysis of observat...
Table S3. MOPHAR monitoring protocol selective serotonin reuptake inhibitors (SSRIs) (DOCX 18 kb
Table S2. MOPHAR monitoring protocol tricyclic antidepressants (TCAs) (DOCX 19 kb
Objective: The main goal of this work was to identify, describe, characterize, and classify the scie...
Complete data of gene sets analyzed. Excel file containing a complete data of all gene sets (neurona...
Description and statistics referred to the SNPs that showed p<0.05 (remission phenotype) in both the...
Table S4. MOPHAR monitoring protocol selective serotonin and noradrenaline reuptake inhibitors (SNRI...
Characteristics of the pathways obtained by functional enrichment analysis when considering the remi...
Description and statistics referred to the SNPs that showed p<0.05 (response phenotype) in both the ...
Additional file 1. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Proto...
Additional file 2: Supplementary File 2. Identification of the studies/publications included in the ...
Additional file 3: Supplementary File 3. Characterization of the studies/publications according to t...
Additional file 5: Supplementary File 5. Levels of evidence and GRADE of the studies included in the...
Additional file 4: Supplementary File 4. Tables with the results related to the drugs, namely the in...
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...
MOOSE Checklist. A list of factors that have been checked or done for this meta-analysis of observat...
Table S3. MOPHAR monitoring protocol selective serotonin reuptake inhibitors (SSRIs) (DOCX 18 kb
Table S2. MOPHAR monitoring protocol tricyclic antidepressants (TCAs) (DOCX 19 kb
Objective: The main goal of this work was to identify, describe, characterize, and classify the scie...
Complete data of gene sets analyzed. Excel file containing a complete data of all gene sets (neurona...
Description and statistics referred to the SNPs that showed p<0.05 (remission phenotype) in both the...
Table S4. MOPHAR monitoring protocol selective serotonin and noradrenaline reuptake inhibitors (SNRI...
Characteristics of the pathways obtained by functional enrichment analysis when considering the remi...
Description and statistics referred to the SNPs that showed p<0.05 (response phenotype) in both the ...
Additional file 1. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Proto...
DOI
Add to ORKG